Free Trial

Organigram (OGI) Stock Forecast & Price Target

0.00 (0.00%)
(As of 07/19/2024 ET)

Organigram - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 4 Wall Street analysts who have issued ratings for Organigram in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 4 analysts, 1 has given a hold rating, and 3 have given a buy rating for OGI.

Consensus Price Target

74.33% Upside
High ForecastC$5.25
Average ForecastC$3.89
Low ForecastC$2.70

According to the 4 analysts' twelve-month price targets for Organigram, the average price target is C$3.89. The highest price target for OGI is C$5.25, while the lowest price target for OGI is C$2.70. The average price target represents a forecasted upside of 74.33% from the current price of C$2.23.

TypeCurrent Forecast
7/20/23 to 7/19/24
1 Month Ago
6/20/23 to 6/19/24
3 Months Ago
4/21/23 to 4/20/24
1 Year Ago
7/20/22 to 7/20/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetC$3.89C$3.76C$3.85C$3.15
Forecasted Upside74.33% Upside46.30% Upside56.15% Upside99.84% Upside
Get Organigram Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.

OGI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OGI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Organigram Stock vs. The Competition

TypeOrganigramMedical Companies
Consensus Rating Score
Consensus RatingModerate BuyModerate Buy
News Sentiment RatingNeutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/17/2024Jefferies Financial Group
2 of 5 stars
 Lower TargetC$4.40 ➝ C$4.35+61.11%
5/15/2024Canaccord Genuity Group
1 of 5 stars
 Lower TargetSpeculative BuyC$3.75 ➝ C$3.25+21.27%
4/3/2024ATB Capital
4 of 5 stars
 Set TargetOutperformC$5.25+76.77%
2/14/2024Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutralC$2.00 ➝ C$2.70+8.43%
7/18/2023Haywood Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$5.00 ➝ C$3.00+60.43%
7/17/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetC$1.25 ➝ C$4.00+104.08%
8/31/2022Eight Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$2.60 ➝ C$1.70+22.30%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 08:49 PM ET.

OGI Forecast - Frequently Asked Questions

What is Organigram's forecast for 2024?

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Organigram is C$3.89, with a high forecast of C$5.25 and a low forecast of C$2.70.

Should I buy or sell Organigram stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last twelve months. There is currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" OGI shares.

Does Organigram's stock price have much upside?

According to analysts, Organigram's stock has a predicted upside of 42.27% based on their 12-month stock forecasts.

What analysts cover Organigram?

Organigram has been rated by research analysts at Canaccord Genuity Group, and Jefferies Financial Group in the past 90 days.

Do Wall Street analysts like Organigram more than its competitors?

Analysts like Organigram more than other "medical" companies. The consensus rating score for Organigram is 2.75 while the average consensus rating score for "medical" companies is 2.72. Learn more on how OGI compares to other companies.

This page (TSE:OGI) was last updated on 7/19/2024 by Staff

From Our Partners